CasLoc logo
All Cases PTAB Litigations UPC Oppositions

TEVA WOMEN'S HEALTH, INC. v. MYLAN PHARMACEUTICALS, INC.

2:10-cv-01234

Overview

Case Number 2:10-cv-01234
Filing Date 2010-03-09
Status Terminated
Termination Date 2012-12-03
Court District Court, D. New Jersey (njd)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

MYLAN INC. Operating Company

Represented By

3 Attorneys Listed

MYLAN PHARMACEUTICALS, INC. Operating Company

Represented By

3 Attorneys Listed

Counter Claimant

FAMY CARE LTD. Operating Company

Represented By

3 Attorneys Listed

Counter Defendant

TEVA WOMEN'S HEALTH, INC. Operating Company

Represented By

1 Attorneys Listed

Court & Judges

Court

District Court, D. New Jersey (njd)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 3 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (3): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US7615545
Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
Filed: 2007-08-17
Issued: 2009-11-10
Expired (Term Ended)
Expires: 2023-06-15

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

28

Dispositive

11

Granted

2

Denied

3

Pending / Review

22

Motions by Category

Procedural / Extension Motion 5 Motion to Compel Discovery 1 Motion to Strike / Sanctions 11 Motion for Summary Judgment (Invalidity) 6 Motion for Summary Judgment (Infringement) 4 Motion for Summary Judgment (Rule 56) 1

Key Dispositive Motions & Rulings

Motion for Summary Judgment (Rule 56) Pending / Under Review
ORDER administratively terminating 138 Motion for Summary Judgment ; administratively terminating 139 Motion for Summary Judgment ; administratively terminating...
Entry #174 • 2012-05-04 Document →
Motion for Summary Judgment (Invalidity) Pending / Under Review
REPLY BRIEF to Opposition to Motion re 141 MOTION for Summary Judgment For Invalidity On U.S. Patent No. 7,615,545 for Anticipation filed by FAMY CARE LTD., MYL...
Entry #167 • 2012-02-01 Document →
Motion for Summary Judgment (Invalidity) Pending / Under Review
Letter from Mylan Inc., Mylan Pharmaceuticals Inc. and Famy Care Ltd. re 138 MOTION for Summary Judgment of Invalidity of U.S. Patent No. 7,615,545 for Obviousn...
Entry #168 • 2012-02-01 Document →
Motion for Summary Judgment (Infringement) Pending / Under Review
REPLY BRIEF to Opposition to Motion re 139 MOTION for Summary Judgment of Noninfringement filed by FAMY CARE LTD., MYLAN INC., MYLAN PHARMACEUTICALS, INC.. (Att...
Entry #166 • 2012-01-31 Document →
Motion for Summary Judgment (Invalidity) Pending / Under Review
BRIEF in Opposition re 141 MOTION for Summary Judgment For Invalidity On U.S. Patent No. 7,615,545 for Anticipation filed by TEVA WOMEN'S HEALTH, INC.. (Attachm...
Entry #150 • 2012-01-13 Document →
Motion for Summary Judgment (Infringement) Pending / Under Review
BRIEF in Opposition re 139 MOTION for Summary Judgment of Noninfringement filed by TEVA WOMEN'S HEALTH, INC.. (Attachments: # 1 Appendix A, # 2 Statement Pursua...
Entry #157 • 2012-01-13 Document →

Docket Entries

(204 total)
Pleading / Complaint

COMPLAINT against FAMY CARE LTD., MYLAN INC., MYLAN PHARMACEUTICALS, INC. ( Filing fee $ 350 receipt number 2995755.) No Summons Attached., filed by TEVA WOMEN'S HEALTH, INC.. (Attachments: # 1 CERT OF NON-ARBITRABILITY, # 2 Civil Cover Sheet)(dr, ) (Entered: 03/11/2010)

Entry #1 • 2010-03-09
1
Pleading / Complaint

COMPLAINT against FAMY CARE LTD., MYLAN INC., MYLAN PHARMACEUTICALS, INC. ( Filing fee $ 350 receipt number 2995755.) No Summons Attached., filed by TEVA WOMEN'S HEALTH, INC.. (Attachments: # 1 CERT OF NON-ARBITRABILITY, # 2 Civil Cover Sheet)(dr, ) (Entered: 03/11/2010)

Entry #1 • 2010-03-09
2
Pleading / Complaint

COMPLAINT against FAMY CARE LTD., MYLAN INC., MYLAN PHARMACEUTICALS, INC. ( Filing fee $ 350 receipt number 2995755.) No Summons Attached., filed by TEVA WOMEN'S HEALTH, INC.. (Attachments: # 1 CERT OF NON-ARBITRABILITY, # 2 Civil Cover Sheet)(dr, ) (Entered: 03/11/2010)

Entry #1 • 2010-03-09
2

Corporate Disclosure Statement by TEVA WOMEN'S HEALTH, INC. identifying NONE as Corporate Parent.. (dr, ) (Entered: 03/11/2010)

Entry #2 • 2010-03-09
1

SUMMONS ISSUED as to FAMY CARE LTD., MYLAN INC., MYLAN PHARMACEUTICALS, INC. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. Issued By *DIANNE C. RICHARDS* (dr, ) (Entered: 03/11/2010)

Entry #3 • 2010-03-09
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc